MARKET WIRE NEWS

Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-04 22:21:49 ET

Castle Biosciences, Inc. (CSTL)

Q2 2025 Earnings Conference Call

August 04, 2025, 04:30 PM ET

Company Participants

Camilla Zuckero - Vice President of Investor Relations & Corporate Affairs

Derek J. Maetzold - Founder, CEO, President & Director

Frank Stokes - CFO & Treasurer

Conference Call Participants

Catherine Walden Ramsey Schulte - Robert W. Baird & Co. Incorporated, Research Division

Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division

Mark Anthony Massaro - BTIG, LLC, Research Division

Mason Owen Carrico - Stephens Inc., Research Division

Puneet Souda - Leerink Partners LLC, Research Division

Subhalaxmi T. Nambi - Guggenheim Securities, LLC, Research Division

Sung Ji Nam - Scotiabank Global Banking and Markets, Research Division

Thomas Flaten - Lake Street Capital Markets, LLC, Research Division

Presentation

Operator

Good afternoon all, and thank you for joining us for the Castle Biosciences' Q2 2025 Earnings Call. As a reminder, this call is being recorded. We will begin today's call with opening remarks and introductions, followed by a question-and-answer session....

Read the full article on Seeking Alpha

For further details see:

Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call Transcript
Castle Biosciences Inc.

NASDAQ: CSTL

CSTL Trading

1.08% G/L:

$25.32 Last:

82,523 Volume:

$25.40 Open:

mwn-alerts Ad 300

CSTL Latest News

CSTL Stock Data

$948,047,644
27,291,396
0.3%
60
N/A
Medical Diagnostics & Screening
Healthcare
US
Friendswood

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App